The present disclosure relates to methods for treating an ANCA associated vasculitis, for example, granulomatosis with polyangiitis (GPA), with compositions comprising an effective amount of certain (2S)N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds of Formula (I), including pharmaceutically acceptable salts thereof, Formula (I) that inhibit dipeptidyl peptidase 1 (DPP1) activity. In one embodiment, the compound of Formula (I) is (2S)N-{(1S)-1-cyano-2-{4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide (INS1007).

##STR00001##

The present disclosure relates generally to processes and systems for producing liquid transportation fuels by converting a feed stream that comprises both isopentane and n-pentane, and optionally, some C6+ hydrocarbons. Isopentane and smaller hydrocarbons are separated to form a first fraction while n-pentane and larger components of the feed stock form a second fraction. Each fraction is then catalytically-activated in a separate reaction zone with a separate catalyst, where the conditions maintained in each zone maximize the conversion of each fraction to olefins and aromatics, while minimizing the production of C1-C4 light paraffins. In certain embodiments, the first fraction is activated at a lower temperature than the second fraction. Certain embodiments additionally comprise mixing at least a portion of the two effluents and contacting with an oligomerization catalyst to provide enhanced yields of aliphatic hydrocarbons that possess the characteristics of a blend component of a liquid transportation fuel or other value-added chemical products.

The present disclosure relates generally to processes and systems for producing liquid transportation fuels by converting a feed stream that comprises both isopentane and n-pentane, and optionally, some C6+ hydrocarbons. Isopentane and smaller hydrocarbons are separated to form a first fraction while n-pentane and larger components of the feed stock form a second fraction. Each fraction is then catalytically-activated in a separate reaction zone with a separate catalyst, where the conditions maintained in each zone maximize the conversion of each fraction to olefins and aromatics, while minimizing the production of C1-C4 light paraffins. In certain embodiments, the first fraction is activated at a lower temperature than the second fraction. Certain embodiments additionally comprise mixing at least a portion of the two effluents and contacting with an oligomerization catalyst to provide enhanced yields of aliphatic hydrocarbons that possess the characteristics of a blend component of a liquid transportation fuel or other value-added chemical products.

The invention relates to a selective hydrogenolysis method for treating a feed rich in aromatic compounds having more than 8 carbon atoms, comprising transforming at least one alkyl group with at least two carbon atoms (ethyl, propyl, butyl, isopropyl, etc.) attached to a benzene ring into at least one methyl group. The invention also relates to the integration of the hydrogenolysis unit into an aromatic complex.

The invention relates to a selective hydrogenolysis method for treating a feed rich in aromatic compounds having more than 8 carbon atoms, comprising transforming at least one alkyl group with at least two carbon atoms (ethyl, propyl, butyl, isopropyl, etc.) attached to a benzene ring into at least one methyl group. The invention also relates to the integration of the hydrogenolysis unit into an aromatic complex.

Provided is a method for the synthesis of a -conjugated system from oligofurans, under conditions involving cycloaddition.

Embodiments of the present disclosure describe catalysts, methods of preparing catalysts, methods of forming hydrocarbons using the catalysts, and the like.

Embodiments of the present disclosure describe catalysts, methods of preparing catalysts, methods of forming hydrocarbons using the catalysts, and the like.

A process for converting naphtha, lower olefin, light aromatic hydrocarbon, and gasoline with a high octane number by combining catalytic cracking of naphtha with steam cracking of lower alkane and catalytic cracking of higher alkanes and higher olefins. The process increases the yield of product with high value and significantly decreases the yield of low value product. At the same time, the power consumption is decreased as a whole since most reactants are converted in catalytic cracking at a lower temperature.

The invention relates to the use of a compound of Formula (I) as described herein and its effective dose in the prevention and/or treatment of fibrosis diseases. The compound can effectively prevent and/or treat a fibrosis disease without cytotoxicity or genotoxicity.